Mirador Capital Partners LP Boosts Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Mirador Capital Partners LP increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 29,698 shares of the financial services provider’s stock after purchasing an additional 187 shares during the period. Mirador Capital Partners LP’s holdings in iShares Biotechnology ETF were worth $3,926,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in IBB. Security National Bank of SO Dak grew its position in iShares Biotechnology ETF by 0.7% during the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after buying an additional 75 shares during the period. SPC Financial Inc. grew its position in iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after buying an additional 75 shares during the period. Werba Rubin Papier Wealth Management grew its position in iShares Biotechnology ETF by 2.7% during the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after buying an additional 76 shares during the period. Capital Investment Advisors LLC grew its position in iShares Biotechnology ETF by 1.0% during the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock worth $1,381,000 after buying an additional 99 shares during the period. Finally, Prairie Wealth Advisors Inc. grew its position in iShares Biotechnology ETF by 6.0% during the second quarter. Prairie Wealth Advisors Inc. now owns 1,765 shares of the financial services provider’s stock worth $242,000 after buying an additional 100 shares during the period. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $133.09 on Thursday. The firm’s 50-day moving average is $137.24 and its two-hundred day moving average is $141.87. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.